Parexel International

OverviewSuggest Edit

Parexel International is a biopharmaceutical services company. It is engaged in providing clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide.

TypePrivate
Founded1983
HQBillerica, MA, US
Websiteparexel.com
Employee Ratings3.6
Overall CultureA

Latest Updates

Employees (est.) (Jun 2021)15,213
Job Openings620
Revenue (FY, 2017)$2.4 B
Share Price (Jul 2017)$87.4
Cybersecurity ratingBMore

Key People/Management at Parexel International

Jamie Macdonald

Jamie Macdonald

CEO
Peyton Howell

Peyton Howell

Executive Vice President, Chief Commercial & Strategy Officer
Greg Rush

Greg Rush

Executive Vice President, Chief Financial Officer
Michael Crowley

Michael Crowley

Executive Vice President, Chief Administrative Officer & General Counsel
Show more

Parexel International Office Locations

Parexel International has offices in Billerica, Baltimore, Bethesda, Durham and in 45 other locations
Billerica, MA, US (HQ)
8 Federal St
Baltimore, MD, US
3001 S Hanover St
Bethesda, MD, US
4600 E W Hwy
Durham, NC, US
2520 Meridian Pkwy #200
Glendale, CA, US
1560 E Chevy Chase Dr
Hackensack, NJ, US
433 Hackensack Ave
Show all (49)

Parexel International Financials and Metrics

Summary Metrics

Founding Date

1983
Show all financial metrics

Parexel International Revenue

Embed Graph
View revenue for all periods
Parexel International's revenue was reported to be $2.44 b in FY, 2017 which is a 0.6% increase from the previous period.
USD

Revenue (FY, 2017)

2.4b

Revenue growth (FY, 2016 - FY, 2017), %

0.6%

Gross profit (FY, 2017)

1.1b

Gross profit margin (FY, 2017), %

43.6%

Net income (FY, 2017)

107.3m

EBIT (FY, 2017)

191.2m

Cash (30-Jun-2017)

302.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2.3b2.3b2.4b2.4b

Revenue growth, %

14%3%4%1%

Cost of goods sold

1.3b1.3b1.4b1.4b

Gross profit

987.2m986.1m1.1b1.1b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

573.7m575.0m576.4m585.2m604.2m611.4m576.5m612.2m605.2m

Cost of goods sold

318.8m327.3m338.0m343.2m332.5m337.8m327.7m350.9m349.6m

Gross profit

254.9m247.7m238.5m242.0m271.7m273.6m248.8m261.3m255.6m

Gross profit Margin, %

44%43%41%41%45%45%43%43%42%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

188.2m207.4m248.6m302.7m

Accounts Receivable

497.1m460.6m506.1m588.2m

Prepaid Expenses

13.6m15.7m23.3m20.6m

Current Assets

1.1b1.1b1.2b1.3b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

281.4m301.9m295.4m157.9m154.0m209.7m325.8m252.4m284.3m

Accounts Receivable

720.0m649.3m705.7m428.1m488.8m558.3m518.0m640.5m573.1m

Prepaid Expenses

24.0m22.8m18.1m29.8m26.7m24.3m32.5m26.7m23.0m

Current Assets

1.1b1.1b1.1b1.0b1.1b1.2b1.2b1.3b1.2b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

129.1m147.8m154.9m107.3m

Depreciation and Amortization

81.3m84.9m96.9m106.4m

Inventories

(10.8m)(3.1m)(17.9m)(4.4m)

Accounts Payable

11.5m19.0m(20.8m)38.9m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

37.1m75.9m113.6m24.9m64.3m112.2m37.8m59.6m77.4m

Depreciation and Amortization

20.4m40.8m62.2m23.7m47.3m71.6m24.8m51.1m78.5m

Cash From Operating Activities

18.9m98.4m98.6m54.2m85.7m130.1m65.4m111.5m261.5m

Purchases of PP&E

(12.1m)(23.6m)(45.6m)(30.9m)(53.3m)(76.8m)(18.8m)(33.2m)(56.7m)
USDFY, 2014

Debt/Equity

0.6 x

Debt/Assets

0.2 x

Financial Leverage

3.2 x
Show all financial metrics

Parexel International Operating Metrics

Parexel International's Backlog was reported to be $4b in FY, 2017.
FY, 2014FY, 2015FY, 2016FY, 2017

Backlog

$5.01 b$5.33 b$5.73 b$3.97 b

Countries

51515252

Facilities

6788

Warehouse Space, sq. ft

2.57 m2.7 m2.86 m2.94 m
Show all operating metrics

Parexel International Acquisitions / Subsidiaries

Company NameDateDeal Size
The Medical Affairs CompanyFebruary 01, 2017
ExecupharmSeptember 26, 2016
Health AdvancesJanuary 20, 2016
Quantum Solutions IndiaMarch 26, 2015
ClinIntel Ltd.October 03, 2014
Atlas Medical Services, Ltd.July 01, 2014
Heron GroupApril 30, 2013$38.2 m
Liquent IncDecember 27, 2012$72 m
ClinPhone plcJune 13, 2008
Parexel APEX International Co., Ltd.September 26, 2007$50.9 m
Show more

Parexel International Revenue Breakdown

Embed Graph

Parexel International revenue breakdown by business segment: 13.3% from PAREXEL Informatics, 9.9% from PAREXEL Consulting Services and 76.8% from Clinical Research Services

Parexel International revenue breakdown by geographic segment: 16.2% from Asia/Pacific, 36.6% from Europe, Middle East & Africa and 47.1% from Americas

Parexel International Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Parexel International Online and Social Media Presence

Embed Graph

Parexel International Company Culture

  • Overall Culture

    A

    76/100

  • CEO Rating

    A

    75/100

  • Compensation

    B-

    68/100

  • Diversity

    C

    63/100

Learn more on Comparably

Parexel International News and Updates

Clinical Trial Management Systems: Global Market Forecasts to 2024, Dominated by Bio-Optronics, MedNet Solutions, Oracle, Parexel International, and IBM

DUBLIN, March 15, 2019 /PRNewswire/ -- The "Clinical Trial Management Systems Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The clinical trial management systems market was valued at USD 665.9 million in 2017. Although the ...

Clinical Trial Management Systems: Global Market Forecasts to 2024, Dominated by Bio-Optronics, MedNet Solutions, Oracle, Parexel International, and IBM

DUBLIN, March 15, 2019 /PRNewswire/ -- The "Clinical Trial Management Systems Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The clinical trial management systems market was valued at USD 665.9 million in 2017. Although the ...

EClinical Solutions Market 2019 Global Analysis By Key Players – Oracle Corporation, Parexel International Corporation, Medidata Solution, Inc., DataTrak International

WiseGuyReports.Com Publish a New Market Research Report On –“ EClinical Solutions Market 2019 Global Analysis By Key Players – Oracle Corporation, Parexel International Corporation, Medidata Solution, Inc., DataTrak International”. Posted via Industry Today. Follow us on Twitter @IndustryToday

In Vivo CRO 2018 Global Market Key Players – Quintiles, Charles River Laboratories, ICON Plc, Covance Inc, Parexel International – Analysis and Forecast to 2025

WiseGuyRerports.com Presents “Global In Vivo CRO Market Size, Status and Forecast 2018-2025” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Parexel International Blogs

Decentralized Trials: Considerations for Building a New Patient-Centric Model

During the past year, patients around the world waiting for new treatments have taken heart that clinical trials have been ongoing, despite the enormous logistical challenges posed by the pandemic. Some delays at the outset were inevitable...

PBPK modeling solutions as a potential risk mitigation strategy for pH dependent DDIs

Drug- Drug Interaction (DDI) is a crucial aspect in new drug development due potential impact on patients’ safety. Pharmacokinetic interactions at the level of absorption, distribution, metabolism and elimination should be considered in any clinical pharmacology submission for regulatory approval.

On the precipice of an impending avalanche of regulatory compliance activity: Are you prepared?

The COVID-19 pandemic brought into sharp focus the vulnerabilities in supply chains for medical products and the importance of ensuring their integrity to provide patient access to critical products. This historical event has also engendered an unprecedented pace in developing, testing, and producin…

Leveraging the draft FDA Guidance on PBPK for your drug development program

In October of 2020, the Food and Drug Administration (FDA) issued draft guidance for the pharmaceutical industry on The Use of Physiologically Based Pharmacokinetic Analyses — Biopharmaceutics Applications for Oral Drug Product Development, Manufacturing Changes, and Controls. The draft guidance off…

We need faster endpoints for targeted cancer drugs, and there is one

As a former regulator, Jorge shares his perspectives for the need of more faster endpoints to measure how targeted cancer drugs can benefit patients. He believes it can be created by combining two commonly used measures. Read more in this short blog.
Show more

Parexel International Frequently Asked Questions

  • When was Parexel International founded?

    Parexel International was founded in 1983.

  • Who are Parexel International key executives?

    Parexel International's key executives are Jamie Macdonald, Peyton Howell and Greg Rush.

  • How many employees does Parexel International have?

    Parexel International has 15,213 employees.

  • What is Parexel International revenue?

    Latest Parexel International annual revenue is $2.4 b.

  • What is Parexel International revenue per employee?

    Latest Parexel International revenue per employee is $160.5 k.

  • Who are Parexel International competitors?

    Competitors of Parexel International include Synexus, ICON and PPD.

  • Where is Parexel International headquarters?

    Parexel International headquarters is located at 8 Federal St, Billerica.

  • Where are Parexel International offices?

    Parexel International has offices in Billerica, Baltimore, Bethesda, Durham and in 45 other locations.

  • How many offices does Parexel International have?

    Parexel International has 49 offices.